AMGEN INC Quarterly Other Assets, Noncurrent in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Amgen Inc quarterly Other Assets, Noncurrent history and growth rate from Q1 2010 to Q3 2024.
  • Amgen Inc Other Assets, Noncurrent for the quarter ending September 30, 2024 was $10.4B, a 32.5% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $10.4B +$2.55B +32.5% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $8.82B +$1.62B +22.6% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $9.01B +$1.37B +18% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $9.61B +$3.71B +62.9% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $7.84B +$1.5B +23.6% Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $7.19B +$1.17B +19.4% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $7.63B +$1.56B +25.8% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 $5.9B -$625M -9.58% Dec 31, 2022 10-K 2024-02-14
Q3 2022 $6.34B +$32M +0.51% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $6.02B +$238M +4.12% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $6.07B +$305M +5.29% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $6.52B +$885M +15.7% Dec 31, 2021 10-K 2023-02-09
Q3 2021 $6.31B +$1.08B +20.5% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $5.78B +$1.14B +24.5% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $5.77B +$1.12B +24.2% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 $5.64B +$3.42B +154% Dec 31, 2020 10-K 2022-02-16
Q3 2020 $5.23B +$3.06B +140% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $4.65B +$2.4B +107% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 $4.64B +$2.5B +117% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $2.22B +$525M +30.9% Dec 31, 2019 10-K 2021-02-09
Q3 2019 $2.18B +$528M +32% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $2.24B +$618M +38% Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $2.14B +$156M +7.87% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $1.7B -$421M -19.9% Dec 31, 2018 10-K 2020-02-12
Q3 2018 $1.65B -$368M -18.3% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $1.63B -$213M -11.6% Jun 30, 2018 10-Q 2018-07-27
Q1 2018 $1.98B +$215M +12.2% Mar 31, 2018 10-Q 2018-04-25
Q4 2017 $2.12B +$494M +30.4% Dec 31, 2017 10-K 2019-02-13
Q3 2017 $2.02B +$114M +5.99% Sep 30, 2017 10-Q 2017-10-26
Q2 2017 $1.84B +$65M +3.67% Jun 30, 2017 10-Q 2017-07-26
Q1 2017 $1.77B -$6M -0.34% Mar 31, 2017 10-Q 2017-04-27
Q4 2016 $1.63B +$26M +1.63% Dec 31, 2016 10-K 2018-02-13
Q3 2016 $1.9B +$152M +8.69% Sep 30, 2016 10-Q 2016-10-28
Q2 2016 $1.77B +$61M +3.56% Jun 30, 2016 10-Q 2016-07-29
Q1 2016 $1.77B -$6M -0.34% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 $1.6B +$132M +9% Dec 31, 2015 10-K 2017-02-14
Q3 2015 $1.75B +$205M +13.3% Sep 30, 2015 10-Q 2015-11-02
Q2 2015 $1.71B +$220M +14.7% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $1.78B +$254M +16.7% Mar 31, 2015 10-Q 2015-04-27
Q4 2014 $1.47B -$300M -17% Dec 31, 2014 8-K 2016-10-31
Q3 2014 $1.55B +$95M +6.55% Sep 30, 2014 10-Q 2014-10-29
Q2 2014 $1.49B +$202M +15.7% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 $1.53B +$377M +32.8% Mar 31, 2014 10-Q 2014-04-30
Q4 2013 $1.77B +$634M +56% Dec 31, 2013 10-K 2015-02-19
Q3 2013 $1.45B +$257M +21.5% Sep 30, 2013 10-Q 2013-10-29
Q2 2013 $1.29B -$39M -2.94% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $1.15B -$289M -20.1% Mar 31, 2013 10-Q 2013-05-03
Q4 2012 $1.13B -$391M -25.7% Dec 31, 2012 10-K 2014-02-24
Q3 2012 $1.19B -$300M -20.1% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $1.33B -$34M -2.49% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 $1.44B +$179M +14.2% Mar 31, 2012 10-Q 2012-05-08
Q4 2011 $1.52B +$253M +19.9% Dec 31, 2011 10-K 2013-02-27
Q3 2011 $1.49B +$181M +13.8% Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $1.36B +$112M +8.95% Jun 30, 2011 10-Q 2011-08-08
Q1 2011 $1.26B +$117M +10.3% Mar 31, 2011 10-Q 2011-05-10
Q4 2010 $1.27B Dec 31, 2010 10-K 2012-02-29
Q3 2010 $1.31B Sep 30, 2010 10-Q 2010-11-08
Q2 2010 $1.25B Jun 30, 2010 10-Q 2010-08-09
Q1 2010 $1.14B Mar 31, 2010 10-Q 2010-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.